Radiotherapy Physics, National Radiotherapy Trials Quality Assurance Group (RTTQA), Mount Vernon Cancer Centre, Northwood, UK.
Belfast Health and Social Care Trust, Belfast, UK; Queen's University Belfast, Belfast, UK.
Clin Oncol (R Coll Radiol). 2022 May;34(5):288-300. doi: 10.1016/j.clon.2022.02.010. Epub 2022 Mar 7.
The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in part as the result of several UK clinical trials and a recent NHS England Commissioning through Evaluation programme. A UK SABR Consortium consensus for normal tissue constraints for SABR was published in 2017, based on the existing literature at the time. The published literature regarding SABR has increased in volume over the past 5 years and multiple UK centres are currently working to develop new SABR services. A review and update of the previous consensus is therefore appropriate and timely. It is hoped that this document will provide a useful resource to facilitate safe and consistent SABR practice.
在过去的十年中，立体定向消融放疗（SABR）在英国的应用范围不断扩大，部分原因是英国的几项临床试验和最近的英格兰国民保健制度通过评估方案。2017 年，英国 SABR 联合会根据当时的现有文献发布了 SABR 正常组织约束的共识，过去 5 年来，有关 SABR 的已发表文献数量有所增加，目前多个英国中心正在努力开发新的 SABR 服务。因此，对之前的共识进行审查和更新是恰当和及时的。希望本文件将成为促进安全和一致的 SABR 实践的有用资源。
